Bob Löwenberg
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.05%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 351
- Acute Myeloid Leukemia Research 289
- Hematopoietic Stem Cell Transplantation 88
- Chronic Myeloid Leukemia Treatments 59
-
- Retinoids in leukemia and cellular processes 42
- Co-authors
- Ruud Delwel (88 shared papers)Peter J.M. Valk (92 shared papers)Alan K. Burnett (14 shared papers)Claudia Erpelinck-Verschueren (32 shared papers)Gert J. Ossenkoppele (47 shared papers)Pieter Sonneveld (62 shared papers)Jan J. Cornelissen (56 shared papers)Elihu H. Estey (8 shared papers)
- Journals
- Blood (184 papers)British Journal of Haematology (35 papers)Journal of Clinical Oncology (21 papers)Leukemia (20 papers)Leukemia Research (13 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Bob Löwenberg
536 papers receiving 36.5k citations
Bob Löwenberg's Hit Papers
Peers
Comparison fields: 5 of 166
- Hematology 23.1k
- Genetics 5.1k
- Oncology 7.3k
- Immunology 5.2k
- Public Health, Environmental and Occupational Health 5.7k
Countries citing papers authored by Bob Löwenberg
This map shows the geographic impact of Bob Löwenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob Löwenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob Löwenberg more than expected).
Fields of papers citing papers by Bob Löwenberg
This network shows the impact of papers produced by Bob Löwenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob Löwenberg. The network helps show where Bob Löwenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Bob Löwenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 549 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Hit paper breakdown → | 2009 | 2443 |
| 2 | Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia Hit paper breakdown → | 2003 | 1926 |
| 3 | Acute Myeloid Leukemia Hit paper breakdown → | 1999 | 1049 |
| 4 | Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia Hit paper breakdown → | 2004 | 1037 |
| 5 | Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse Hit paper breakdown → | 2001 | 707 |
| 6 | Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet Hit paper breakdown → | 2008 | 656 |
| 7 | DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia Hit paper breakdown → | 2010 | 620 |
| 8 | High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia Hit paper breakdown → | 2009 | 615 |
| 9 | Therapeutic Advances in Acute Myeloid Leukemia Hit paper breakdown → | 2011 | 606 |
| 10 | Report of an international working group to standardize response criteria for myelodysplastic syndromes. Hit paper breakdown → | 2000 | 540 |
| 11 | 2005 | 456 | |
| 12 | 2009 | 414 | |
| 13 | 2008 | 409 | |
| 14 | 1995 | 383 | |
| 15 | 2005 | 369 | |
| 16 | 2007 | 363 | |
| 17 | 2005 | 347 | |
| 18 | 2008 | 336 | |
| 19 | 1989 | 319 | |
| 20 | 2002 | 316 |
About Bob Löwenberg
Bob Löwenberg is a scholar working on Hematology, Molecular Biology, Oncology, Immunology and Genetics, having authored 549 papers that have together received 37.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (289 papers), Hematopoietic Stem Cell Transplantation (88 papers), Acute Lymphoblastic Leukemia research (65 papers), Chronic Myeloid Leukemia Treatments (59 papers), Retinoids in leukemia and cellular processes (42 papers), Immune Cell Function and Interaction (39 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (32 papers) and Chronic Lymphocytic Leukemia Research (31 papers). The work is most often cited by research in Hematology (23.1k citations), Genetics (5.1k citations), Oncology (7.3k citations), Immunology (5.2k citations) and Public Health, Environmental and Occupational Health (5.7k citations). Bob Löwenberg has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Ruud Delwel, Peter J.M. Valk, Alan K. Burnett, Claudia Erpelinck-Verschueren, Gert J. Ossenkoppele, Pieter Sonneveld, Jan J. Cornelissen, Elihu H. Estey, James R. Downing and Ivo P. Touw. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Leukemia and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.